Skip to main content

UBS Group AG

Position in ABVX — Abivax S.A.

CIK 1610520 ZURICH, V8

Position in ABVX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$245,853,771
-$260,499,885 QoQ
Shares Held
1,844,918
-59.4% QoQ
Ownership
2.11%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#6
of 299 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABVX Over Time

Shares Held

Position Value (USD)

Derivatives in ABVX

reported options exposure · as of Jun 30, 2026
CallValue
$1,958,922
CallShares
14,700
PutValue
$133,260
PutShares
1,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,271,661 across 562 Biotechnology names. ABVX ranks #7 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 ABVX
Abivax S.A.
This page
1,844,918 $245,853,771

All Filings in ABVX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $245,853,771 1,844,918
2026-06-30 $1,958,922 14,700
2026-06-30 $133,260 1,000
2026-03-31 $506,353,656 4,547,406
2025-12-31 $596,585,843 4,423,906
2025-09-30 $378,761,143 4,461,262
2025-06-30 $1,282,568 167,656
2025-03-31 $1,015,962 162,554
2024-12-31 $1,280,070 174,873
2024-09-30 $7,960 691
2024-03-31 $42 3